Antimicrobial Agents Practice Questions

Q: Which drug is NOT used in the treatment of visceral leishmaniasis?

Hydroxychloroquine. **Explanation:** Visceral Leishmaniasis (Kala-azar), caused by *Leishmania donovani*, requires specific antiprotozoal therapy. **Hydroxychloroquine (Option D)** is the correct answer because it is an antimalarial and immunomodulatory drug (used in SLE and Rheumatoid Arthritis) with no clinical efficacy against *Leishmania* species. **Analysis of Options:** * **Stibogluconate (Option A):** A pentavalent antimonial (SbV) that was historically the first-line treatment. However, significant resistance has developed, particularly in the Bihar region of India. * **Paromomycin (Option B):** An aminoglycoside antibiotic that acts as a potent leishmanicidal agent by inhibiting protein synthesis. It is often used in combination therapies. * **Miltefosine (Option C):** This is the **only oral drug** available for visceral leishmaniasis. It is highly effective but contraindicated in pregnancy due to its teratogenic potential. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Liposomal **Amphotericin B** is currently the drug of choice for Visceral Leishmaniasis in India (single dose 10mg/kg). * **Post-Kala-azar Dermal Leishmaniasis (PKDL):** Miltefosine is commonly used for the extended treatment required in PKDL cases. * **Vector:** The disease is transmitted by the bite of the female sandfly (*Phlebotomus argentipes*). * **Diagnostic Gold Standard:** Demonstration of LD bodies (Amastigotes) in splenic or bone marrow aspirates. The rK39 rapid antigen test is used for field diagnosis.

Q: Which of the following agents does not cause pseudomembranous enterocolitis?

Vancomycin. **Explanation:** **Pseudomembranous enterocolitis** is caused by the overgrowth of *Clostridioides difficile* (C. diff) following the suppression of normal intestinal flora by broad-spectrum antibiotics. **Why Vancomycin is the correct answer:** Vancomycin (specifically the oral formulation) is actually a **treatment** for pseudomembranous enterocolitis. It is a glycopeptide antibiotic that is not absorbed from the GI tract, allowing it to reach high concentrations in the colon where it kills *C. difficile*. Because it targets the causative organism rather than predisposing the patient to its overgrowth, it does not cause the condition. **Analysis of incorrect options:** Almost any antibiotic can theoretically cause C. diff infection, but certain classes are notorious "high-risk" triggers: * **Clindamycin (Option C):** Historically the most classically associated antibiotic with pseudomembranous colitis. * **Ceftazidime (Option D):** 3rd and 4th generation Cephalosporins are currently the most common triggers in hospital settings due to their broad-spectrum activity. * **Levofloxacin (Option B):** Fluoroquinolones are frequently implicated in outbreaks and are major risk factors for C. diff. **NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** Oral Vancomycin or Fidaxomicin are the first-line treatments for C. diff. * **Metronidazole:** Previously the first-line agent, it is now reserved for mild cases if Vancomycin is unavailable. * **Mechanism:** *C. difficile* produces Toxin A (enterotoxin) and Toxin B (cytotoxin); Toxin B is primarily responsible for the mucosal damage and "pseudomembrane" formation. * **Diagnosis:** Confirmed by detecting C. diff toxins in stool or via sigmoidoscopy showing yellow-white plaques.

Q: All of the following toxicities are known with linezolid, EXCEPT:

Vomiting. **Explanation:** Linezolid is an oxazolidinone antibiotic used primarily for resistant Gram-positive infections like MRSA and VRE. The question asks for the exception among its known toxicities. While gastrointestinal upset can occur with many antibiotics, **Vomiting** is not considered a characteristic or "signature" toxicity of linezolid in the context of medical examinations, whereas the other options are classic, high-yield side effects associated with its unique mechanism of action. **Analysis of Options:** * **Thrombocytopenia (Option A):** This is the most common hematologic abnormality. Linezolid causes reversible bone marrow suppression (myelosuppression), particularly when used for more than 2 weeks. Monitoring CBC is mandatory. * **Lactic Acidosis (Option B):** Linezolid can inhibit mitochondrial protein synthesis. This mitochondrial toxicity leads to a shift toward anaerobic metabolism, resulting in lactic acidosis. * **Peripheral Neuropathy (Option D):** Long-term use (usually >28 days) is strongly associated with both peripheral and optic neuropathy. Optic neuropathy can lead to vision loss and requires immediate discontinuation. **Clinical Pearls for NEET-PG:** 1. **MAO Inhibition:** Linezolid is a non-selective inhibitor of Monoamine Oxidase (MAO). It can precipitate **Serotonin Syndrome** if co-administered with SSRIs or tyramine-rich foods. 2. **Mechanism:** It inhibits protein synthesis by binding to the **23S ribosomal RNA of the 50S subunit**, preventing the formation of the 70S initiation complex. 3. **Resistance:** Resistance occurs via mutations in the 23S rRNA. 4. **Bioavailability:** It has nearly **100% oral bioavailability**, allowing an easy switch from IV to oral dosing.

Q: Which drug is useful in treating chloroquine-resistant malaria?

Mefloquine. The treatment of chloroquine-resistant *Plasmodium falciparum* (CRPF) requires drugs that remain effective despite the parasite's efflux mechanisms. **Mefloquine** is a high-yield choice for this purpose [1, 2].

Q: Which of the following aminoglycosides carries the highest risk of neuromuscular blockade?

Neomycin. ### Explanation **Correct Answer: B. Neomycin** **Mechanism of Neuromuscular Blockade (NMB):** Aminoglycosides can induce neuromuscular blockade by inhibiting the pre-junctional release of **Acetylcholine (ACh)** and reducing the sensitivity of the post-junctional nicotinic receptors. This effect is primarily due to the competitive inhibition of **Calcium ions** at the presynaptic nerve terminal. Among all aminoglycosides, **Neomycin** is the most potent inhibitor of ACh release, followed closely by Kanamycin [1]. Because of this high toxicity profile, Neomycin is never administered parenterally; it is restricted to topical use or oral administration for bowel preparation/hepatic coma. **Analysis of Incorrect Options:** * **D. Kanamycin:** While Kanamycin carries a significant risk of NMB (second only to Neomycin), it is clinically less potent in this regard than Neomycin [1]. The use of kanamycin has declined because it is among the most toxic aminoglycosides [1]. * **A. Tobramycin & C. Amikacin:** These are commonly used parenteral aminoglycosides. While they still carry a theoretical risk of NMB, their potential to cause respiratory paralysis is significantly lower than that of Neomycin or Kanamycin. **NEET-PG High-Yield Clinical Pearls:** 1. **Order of Potency for NMB:** Neomycin > Kanamycin > Amikacin > Gentamicin > Tobramycin. 2. **Reversal:** Aminoglycoside-induced NMB is best reversed by **Intravenous Calcium Gluconate** (antagonizes the calcium-blocking effect). Neostigmine may also be used but is less reliably effective [2]. 3. **Contraindication:** Aminoglycosides are strictly contraindicated in patients with **Myasthenia Gravis**, as they can precipitate a severe myasthenic crisis. 4. **Drug Interaction:** Risk increases significantly when used concurrently with skeletal muscle relaxants (e.g., Succinylcholine or Vecuronium) [3].

Q: Which is the longest acting oral sulfonamide?

Sulphadoxine. **Explanation:** Sulfonamides are classified based on their pharmacokinetic profile, specifically their duration of action, which is determined by their rate of renal excretion and protein binding. **Why Sulphadoxine is correct:** **Sulphadoxine** is categorized as an **ultra-long-acting sulfonamide**. It has an exceptionally long half-life of approximately **7 to 9 days (170–200 hours)**. This is due to its high degree of plasma protein binding and slow renal clearance. Because of this prolonged action, it is not used for routine infections but is primarily used in combination with Pyrimethamine (Fansidar) for the prophylaxis and treatment of chloroquine-resistant *Plasmodium falciparum* malaria. **Analysis of Incorrect Options:** * **Sulphadiazine:** This is a **short-acting** sulfonamide with a half-life of about 10 hours. It is commonly used in the treatment of UTI and, in combination with pyrimethamine, is the first-line treatment for Toxoplasmosis. * **Sulphacetamide:** This is a highly soluble sulfonamide used primarily **topically** in the eye for bacterial conjunctivitis. It is not used for its systemic long-acting properties. * **Mafenide:** This is a **topical** sulfonamide used primarily in burn dressings to prevent infection (especially *Pseudomonas*). It is not administered orally for systemic effect and is known for causing metabolic acidosis as a side effect. **High-Yield NEET-PG Pearls:** * **Mechanism of Action:** Sulfonamides are structural analogs of PABA; they competitively inhibit **Dihydropteroate Synthase**. * **Shortest acting sulfonamide:** Sulfisoxazole. * **Drug of choice for Nocardiosis:** Sulfonamides (usually Cotrimoxazole). * **Key Side Effect:** Stevens-Johnson Syndrome (SJS) and Crystalluria (prevented by alkalinizing urine and increasing fluid intake).

Q: Ivermectin acts by?

Activation of Glutamate-gated Chloride channels. **Mechanism of Action: Ivermectin** **Correct Answer: C. Activation of Glutamate-gated Chloride channels** Ivermectin is a broad-spectrum anthelmintic agent that works by binding selectively and with high affinity to **glutamate-gated chloride ion channels** located in invertebrate nerve and muscle cells. This binding increases the permeability of the cell membrane to chloride ions, leading to **hyperpolarization** of the nerve or muscle cell. The result is tonic paralysis and eventual death of the parasite. In humans, ivermectin does not easily cross the blood-brain barrier, which protects our GABA receptors from similar effects. **Analysis of Incorrect Options:** * **A. Inhibition of pyruvate ferredoxin oxidoreductase:** This is the mechanism of action for **Nitazoxanide** and **Metronidazole** (in anaerobic bacteria/protozoa like *Giardia* and *Entamoeba*). It interferes with anaerobic energy metabolism. * **B. Inhibition of Nicotinic Acetylcholine receptor:** This describes the action of neuromuscular blockers or certain insecticides. In contrast, **Pyrantel pamoate** acts as a nicotinic receptor *agonist* (depolarizing neuromuscular blocker) in helminths. * **D. Inhibition of heme polymerase:** This is the mechanism of **Chloroquine** and other aminoquinolines. It prevents the detoxification of heme into hemozoin in malaria parasites, leading to toxic heme accumulation. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Strongyloidiasis, Onchocerciasis (River blindness), Scabies (oral), and *Larva currens*. * **Mazzotti Reaction:** A severe immune response (fever, rash, hypotension) seen after treating Onchocerciasis with ivermectin due to the rapid death of microfilariae. * **Safety:** Contraindicated in conditions where the blood-brain barrier is compromised (e.g., meningitis, African Sleeping Sickness).

Q: Which of the following drugs is useful in the treatment of infection by Mycobacterium avium complex?

Clarithromycin. **Explanation:** *Mycobacterium avium* complex (MAC) is a group of non-tuberculous mycobacteria (NTM) that frequently causes opportunistic infections in immunocompromised patients, particularly those with HIV/AIDS (CD4 count <50 cells/mm³). **Why Clarithromycin is correct:** Clarithromycin (or Azithromycin) is the **drug of choice** for both the prophylaxis and treatment of MAC infections. Macrolides inhibit protein synthesis by binding to the 50S ribosomal subunit. For active MAC infection, Clarithromycin is typically used in combination with Ethambutol and sometimes Rifabutin to prevent the emergence of resistance. **Why the other options are incorrect:** * **Isoniazid (A):** While it is a primary (first-line) drug for *M. tuberculosis*, MAC is intrinsically resistant to Isoniazid due to differences in the cell wall and metabolic pathways. * **Cycloserine (C):** This is a second-line drug used for Multidrug-Resistant Tuberculosis (MDR-TB). It has minimal clinical utility against MAC. * **Rifampicin (D):** Although Rifampicin is a first-line anti-TB drug, it is generally less effective against MAC than its derivative, **Rifabutin**, which is preferred in MAC regimens due to higher potency and fewer drug interactions in HIV patients. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis:** Start Azithromycin or Clarithromycin in HIV patients when CD4 count falls below **50 cells/mm³**. * **Treatment Regimen:** The standard "triple therapy" for MAC includes **Clarithromycin + Ethambutol + Rifabutin**. * **Side Effect:** Monitor for metallic taste and GI upset with Clarithromycin; monitor for uveitis and orange discoloration of secretions with Rifabutin.

Q: What is the recommended dose and duration of benzathine penicillin G for the prophylaxis of rheumatic fever?

1.2 MU every 4 weeks. **Explanation:** **1. Understanding the Correct Answer (Option B):** Rheumatic fever prophylaxis aims to prevent recurrent Group A Streptococcal (GAS) pharyngitis, which can trigger a recurrence of rheumatic fever. **Benzathine Penicillin G** is the drug of choice because it is a long-acting repository form that releases penicillin slowly into the systemic circulation. The standard recommended dose for secondary prophylaxis in adolescents and adults (or children >27 kg) is **1.2 million units (MU) administered intramuscularly every 4 weeks.** In high-risk situations or areas with high endemicity, the frequency may be increased to every 3 weeks, but the standard textbook and guideline answer remains every 4 weeks. **2. Analysis of Incorrect Options:** * **Option A (1.2 MU every 2 weeks):** This frequency is too high for standard prophylaxis and increases the risk of injection site pain and non-compliance without significant added benefit for most patients. * **Options C & D (2.4 MU):** A dose of 2.4 MU is typically reserved for the treatment of **Syphilis** (Primary, Secondary, or Early Latent). Using this dose for rheumatic fever prophylaxis would be excessive and is not supported by clinical guidelines. **3. High-Yield Clinical Pearls for NEET-PG:** * **Duration of Prophylaxis:** * *RF without Carditis:* 5 years or until age 21 (whichever is longer). * *RF with Carditis (no residual heart disease):* 10 years or until age 21 (whichever is longer). * *RF with Carditis + Persistent Valvular Disease:* 10 years or until age 40 (sometimes lifelong). * **Alternative:** If the patient is allergic to penicillin, **Erythromycin (250 mg BD)** or **Azithromycin** is used. * **Route:** Benzathine Penicillin must be given **Intramuscularly (IM)**; accidental IV administration can cause cardiac arrest (Hoigne’s syndrome).

Question 1

Which drug is NOT used in the treatment of visceral leishmaniasis?

Accepted Answer

Hydroxychloroquine

Answer

Stibogluconate

Answer

Paromomycin

Answer

Miltefosine

Question 2

Which of the following agents does not cause pseudomembranous enterocolitis?

Accepted Answer

Vancomycin

Answer

Levofloxacin

Answer

Clindamycin

Answer

Ceftazidime

Question 3

All of the following toxicities are known with linezolid, EXCEPT:

Accepted Answer

Vomiting

Answer

Thrombocytopenia

Answer

Lactic acidosis

Answer

Peripheral neuropathy

Question 4

Which drug is useful in treating chloroquine-resistant malaria?

Accepted Answer

Mefloquine

Answer

Proguanil

Answer

Pyrimethamine

Answer

Primaquine

Question 5

Which of the following aminoglycosides carries the highest risk of neuromuscular blockade?

Accepted Answer

Neomycin

Answer

Tobramycin

Answer

Amikacin

Answer

Kanamycin

Question 6

Which is the longest acting oral sulfonamide?

Accepted Answer

Sulphadoxine

Answer

Sulphadiazine

Answer

Sulphacetamide

Answer

Mafenide

Question 7

Ivermectin acts by?

Accepted Answer

Activation of Glutamate-gated Chloride channels

Answer

Inhibition of pyruvate ferridoxin oxidoreductase

Answer

Inhibition of Nicotinic Acetylcholine receptor

Answer

Inhibition of heme polymerase

Question 8

Which of the following drugs is useful in the treatment of infection by Mycobacterium avium complex?

Accepted Answer

Clarithromycin

Answer

Isoniazid

Answer

Cycloserine

Answer

Rifampicin

Question 9

A 50-year-old female with end-stage renal disease (ESRD) develops pulmonary tuberculosis. Which one of the following antitubercular drugs should be used in a reduced dose?

Accepted Answer

Ethambutol

Answer

Rifampicin

Answer

Isoniazid

Answer

Pyrazinamide

Question 10

What is the recommended dose and duration of benzathine penicillin G for the prophylaxis of rheumatic fever?

Accepted Answer

1.2 MU every 4 weeks

Answer

1.2 MU every 2 weeks

Answer

2.4 MU every 2 weeks

Answer

2.4 MU every 4 weeks

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?